Population Covered By The Guidance
This pathway provides guidance on the investigation of adult patients with hyperthyroidism.
Lead Researcher: Sian Chin, Arjun Shivananda
Experts & Contributors: Ravinder Dhillon, David Hurley, Anita Kothapalli, Kyaw Thura
Editorial Panel: Core membership
Link to Editorial Panel
Date reviewed: February 2018
Date Published: June 2018
- Graves' disease can often be diagnosed clinically and appropriate medication commenced
- If the aetiology of hyperthyroidism is uncertain, isotope scan may aid in the diagnosis based on the pattern and location of radionuclide uptake
Date of literature search: September 2017
References are graded from Level I to V according to the Oxford Centre for Evidence-Based Medicine, Levels of Evidence. Download the document
- De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016;388(10047):906-18. (Review article). View the reference
- Lacka K, Fraczek MM. Classification and etiology of hyperthyroidism. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. 2014;36(213):206-11. (review article). View the reference
- Meller J, Becker W. The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound. Eur J Nucl Med Mol Imaging. 2002;29 Suppl 2:S425-38. (Review article). View the reference
- Summaria V, Salvatori M, Rufini V, Mirk P, Garganese MC, Romani M. Diagnostic imaging in thyrotoxicosis. Rays. 1999;24(2):273-300. (Review article). View the reference
- Alimanovic-Alagic R, Brkovic A, Kucukalic-Selimovic E, Skopljak-Beganovic A. Thyroid scintigraphy as diagnostic method evaluation of thyroid diseases. Med Arh. 2008;62(2):114-6. (Review article). View the reference
- Smith JR, Oates E. Radionuclide imaging of the thyroid gland: patterns, pearls, and pitfalls. Clin Nucl Med. 2004;29(3):181-93. (Review article). View the reference
- Intenzo CM, dePapp AE, Jabbour S, Miller JL, Kim SM, Capuzzi DM. Scintigraphic manifestations of thyrotoxicosis. Radiographics. 2003;23(4):857-69. (Review article). View the reference
- Kusic Z, Becker DV, Saenger EL, Paras P, Gartside P, Wessler T, et al. Comparison of technetium-99m and iodine-123 imaging of thyroid nodules: correlation with pathologic findings. J Nucl Med. 1990;31(4):393-9. (Level III evidence). View the reference
- Gupta V. Physiopathologic atlas of thyroid scintigraphy. Kathmandu University medical journal (KUMJ). 2007;5(4):583-90. (Review article). View the reference
- Meng Z, Zhang G, Sun H, Tan J, Yu C, Tian W, et al. Differentiation between Graves' disease and painless thyroiditis by diffusion-weighted imaging, thyroid iodine uptake, thyroid scintigraphy and serum parameters. Experimental and Therapeutic Medicine. 2015;9(6):2165-72. (Level III evidence). View the reference
Pathway User Guide
Yellow Boxes Denotes extra information. Some contain single or multiple white sub-boxes, click a white box to reveal detailed information in a pop-up.
White Boxes: Denotes standard pathway steps. (If inside a yellow box, they open a specific pop-up).
Zoom & Pan Controls: Use + / − or the slider to zoom. Reset returns to default. Tick Panning to drag the diagram when zoomed.
Blue “View Full Screen” Button: Opens the whole diagram in a large, full-screen pop-up window. Use Close to exit.
The relative radiation level (RRL) of each imaging investigation is displayed in the pop up box.
| SYMBOL | RRL | EFFECTIVE DOSE RANGE |
|---|---|---|
| None | 0 | |
| Minimal | < 1 millisieverts | |
| Low | 1-5 mSv | |
| Medium | 5-10 mSv | |
| High | >10 mSv |
Disclaimer
Status Of Recommendations Each pathway is designed to assist clinicians in situations when faced with a large array of possible diagnostic tests and examinations. However, it is recognised that diagnostic practice may differ from a particular pathway depending on local availability of equipment and expertise, as well as the experience of individual clinicians. Therefore each pathway is neither a rigid set of rules, nor a substitute for clinical assessment, and individual patient circumstances should always be considered.
Spotted an error or outdated info? Click to tell us.
Hyperthyroidism
Hyperthyroidism
Defined as elevated serum free T4 and/or T3 with typical symptoms and signs
- Hyperthyroidism is diagnosed when there is elevation of serum free T4 and/or T3 accompanied by typical symptoms and signs. Biochemical evidence without clinical manifestations is referred to as subclinical hyperthyroidism. Antibody interference in thyroid assays should be considered when interpreting results
- Common causes of hyperthyroidism include Graves' disease and toxic multinodular goitre; also consider functioning thyroid adenoma and thyroiditis
- The role of imaging in hyperthyroidism is to help establish the cause and this is usually done with a thyroid isotope scan
- Elevated T3 and T4 are usually accompanied by low levels of TSH. However, rarely hyperthyroidism is driven by high TSH levels in which case a TSH-secreting pituitary adenoma or thyroid hormone resistance should be excluded
- Typical cases of Graves' disease such as those with a diffuse goitre, ophthalmopathy and serological evidence may treated without any prior imaging although scintigraphy may help confirm the diagnosis and exclude other causes
Thyroid Hormone Resistance
Thyroid Hormone Resistance
A rare genetic syndrome where thyroid hormone levels are elevated but TSH is not suppressed, caused by an inactivation mutation of the thyroid receptor gene
Typical Signs of Graves’ Disease Include
Typical Signs of Graves’ Disease Include
- Hyperthyroidism
- Ophthalmopathy
- Diffuse goitre
- Thyrotropin (TSH) receptor antibodies
Thyroid Isotope Scan (Thyroid Scintigraphy)
Thyroid Isotope Scan
Usually performed with technetium-99m pertechnetate
- Usually performed with technetium-99m pertechnetate or radioiodine
- Advantages of technetium-99m pertechnetate
- Lower radiation dose
- Better image quality
- Less waiting time after administration
- Wider availability
- Lower cost
- Images can be obtained while the patient is taking anti-thyroid medications
- Advantages of radioiodine
- Has lower levels of vascular background activity which is useful when assessing retrosternal masses
- Has some advantages in the evaluation of thyroid nodules, although these are rarely of clinical significance
- Oral administration
- Scintigraphy is particularly useful for distinguishing Graves' disease from conditions such as subacute, silent and postpartum thyroiditis and factitious hyperthyroidism
- It is also useful for demonstrating toxic adenomas
